e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
High eosinophil counts predict decline in FEV
1
: results from the CanCOLD study
Wan C. Tan, Jean Bourbeau, Gilbert Nadeau, Wendy Wang, Neil Barnes, Sarah H. Landis, Miranda Kirby, James C. Hogg, Don D. Sin
Source:
Eur Respir J, 57 (5) 2000838; 10.1183/13993003.00838-2020
Journal Issue:
May
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Wan C. Tan, Jean Bourbeau, Gilbert Nadeau, Wendy Wang, Neil Barnes, Sarah H. Landis, Miranda Kirby, James C. Hogg, Don D. Sin. High eosinophil counts predict decline in FEV
1
: results from the CanCOLD study. Eur Respir J, 57 (5) 2000838; 10.1183/13993003.00838-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Imaging of eosinophilic lung disease
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Elevated baseline blood eosinophil count is related to greater lung function decline over 20-years of follow-up.
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019
Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD?
Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Year: 2019
Low versus high Th2 asthma: variability of blood eosinophil counts in a longitudinal analysis
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021
Elevated blood neutrophil levels in GOLD 2017 COPD group D – results from the TIE-study
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Correlations between exacerbation rate and blood eosinophil levels in COPD patients
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019
Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA)
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020
Correlation between serum levels of C-reactive protein and peak expiratory flow in persistent asthma: A longitudinal study
Source: Annual Congress 2010 - Occupational and environmental exposures and respiratory disease
Year: 2010
Maximally attained level of FEV
1
and FEV
1
decline determine airway hyperresponsiveness in adults
Source: Eur Respir J 2003; 22: Suppl. 45, 17s
Year: 2003
Budesoinde/formoterol: does eosinophil count cause different outcomes?
Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Year: 2019
Reproducibility of COPD blood eosinophil counts
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018
Response to omalizumab treatment according to blood eosinophil count: Results of a French real-world study (STELLAIR)
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017
A study on the relevance of eosinophil counts in induced sputum and FENO and lung functions in asthmatics
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
The reproducibility of COPD blood eosinophil counts
Source: Eur Respir J, 52 (1) 1800427; 10.1183/13993003.00427-2018
Year: 2018
Subjects in a population study with high levels of FENO have associated eosinophil airway inflammation in BAL
Source: Eur Respir J 2004; 24: Suppl. 48, 469s
Year: 2004
Blood eosinophil (EOS) count, exacerbation rate and response to roflumilast in patients with severe COPD
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017
The impact of high eosinophil count on hospitalizations in COPD patients
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Impact of blood eosinophil variability in asthma: a real-life population study.
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021
Has the determination of the rate of decline of FEV1 added value in addition to the determination of FEV1/FVC and FEV1
Source: International Congress 2016 – Man versus machine: waves, frequency, and more in lung function
Year: 2016
A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial
Source: Eur Respir J, 58 (3) 2004522; 10.1183/13993003.04522-2020
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept